© 2020 MJH Life Sciences and Practical Cardiology. All rights reserved.
© 2020 MJH Life Sciences™ and Practical Cardiology. All rights reserved.
September 28, 2020
September 27, 2020
September 25, 2020
September 24, 2020
September 23, 2020
Check out the latest coverage of the European Society of Cardiology Congress 2020
New data suggest resuming or increasing sexual activity shortly after myocardial infarction could reduce risk of mortality.
September 22, 2020
Our latest Emergency Department Minute Quiz from Brady Pregerson, MD. Can you determine the correct diagnosis?
September 21, 2020
Chief member of Practical Cardiology's editorial advisory board discusses his approach to cholesterol education and the current state of cholesterol management in 2020.
September 19, 2020
Results of the analysis offer further clarity on the detrimental impact of smoking on overall and cerebrovascular health.
September 18, 2020
A meta-analysis of more than 3 dozen RCTs suggests increased intake of omega-3 supplements, such as EPA and DHA, was linked to a decreased risk of myocardial infarction action and coronary heart disease events.
September 17, 2020
With September recognized as National Cholesterol Education Month, Dr. Weiss reflects on the importance of cholesterol management as part of mitigating risk of events in patients with ASCVD.
September 16, 2020
An unresponsive older man presents to the emergency department after bystanders report he was thrashing around unconscious at a fast-food restaurant.
September 15, 2020
September 12, 2020
Data from more than 4500 diabetics suggest CAC was better at predicting CVD and all-cause mortality in women than in men.
September 11, 2020
A study published in an AHA journal describes recent trends, predictors, and outcomes of stroke in patients with hypertensive disorders of pregnancy.
September 09, 2020
A study from ESC Congress 2020 dove deeper into associations between specific biomarkers and risk of CV events in CAD patients with and without diabetes.
September 08, 2020
September 07, 2020
Dr. Gregory Weiss compiles thoughts and perspective on hot line trials presented at ESC Congress 2020.
September 06, 2020
Lead investigator of the PARALLAX trial discusses whether he feels clinical data related to sacubitril/valsartan is strong enough to warrant prescribing it for HFpEF patients.
September 05, 2020
Paul Thompson, MD, offers perspective on the use of ezetimibe in a clinical setting.
September 04, 2020
Deepak Bhatt, MD, of Brigham and Women's Hospital, offers perspective on REDUCE-IT analyses and icosapent ethyl (Vascepa) data presented at ESC Congress 2020.